IP Library Granted Patent US 9,073,896
Granted Patent B2
US 9,073,896 · App. 13/864,916 · Granted Jul 7, 2015

Compounds that inhibit human DNA ligases and methods of treating cancer

Inventors: Alan E. Tomkinson (Albuquerque, NM); Helen Xi Chen (Austin, TX); Barbara Dziegielewska (Charlottesville, VA); Alexander D. Mackerell (Baltimore, MD); Shijun Zhong (Catonsville, MD); Gerald M. Wilson (Middle River, MD)
Assignee: University of Maryland, Baltimore
C07D407/12A61K31/397C07D307/68A61K31/175A61K31/341A61K31/404A61K31/41A61K31/4184A61K31/423A61K31/4245A61K31/428A61K31/433A61K31/436A61K31/4439A61K31/495A61K31/553A61K45/06C07D209/30C07D235/28C07D257/04C07D263/58C07D267/18C07D271/12C07D277/74C07D285/14C07D401/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,073,896
App. No.
13/864,916
Granted
Jul 7, 2015
Kind
B2
Abstract

Methods for treating cancer using compounds that inhibit human DNA ligases. Methods for using compounds that inhibit human DNA ligases to provide insights into the reaction mechanisms of human DNA ligases, for example to identify the human DNA ligase involved in different DNA repair pathways. Screening methods for compounds that inhibit human DNA ligases.

Claims (8)

1. A method of treating colon cancer exhibiting an altered DNA damage response in a patient in need comprising administering to said patient an effective amount of an anti-cancer compound according to the chemical structure as set forth below:

in combination with a second cancer treatment comprising a DNA damaging agent wherein said DNA damaging agent is ionizing radiation.

2. The method of claim 1 , wherein said DNA damaging agent is administered at the same time as administering said compound.

3. The method of claim 1 , wherein said DNA damaging agent is administered prior to administering said at least one compound.

4. The method of claim 1 , wherein said DNA damaging agent is administered after administering said at least one compound.

5. A method of treating colon cancer in a patient in need comprising administering to said patient an effective amount of an anti-cancer compound according to the chemical structure as set forth below:

in combination with a second cancer treatment comprising a DNA damaging agent, wherein said DNA damaging agent is ionizing radiation.

6. A pharmaceutical composition comprising a therapeutically effective amount of a compound according to the chemical structure:

Assignments (1)
CONFIRMATORY LICENSE Recorded Jul 5, 2016
From: UNIVERSITY OF MARYLAND BALTIMORE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039073/0258 →
Continuity (4)
Division 12576410 · Oct 9, 2009
Continuation In Part PCTUS2008059931 · Apr 10, 2008
Provisional Application 60911000 · Apr 10, 2007
Related Publication 20140113891A1 · Apr 24, 2014